We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New Active Substance Fee Outlined in Updated Health Canada Guidance
New Active Substance Fee Outlined in Updated Health Canada Guidance
July 10, 2013
Fees for new drug reviews and applications in Canada rose by about 2 percent last month, according to updated guidance posted June 19 by Health Canada.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor